Arun Balaji

Arun Balaji is a manager and US lead regulatory strategist at Pfizer since June 2021, with extensive experience in regulatory strategy for rare diseases, patient impact assessments, and sourcing oversight. Previously, Arun served as a business process analyst co-op, where significant improvements were made to clinical trial processes, demonstrating strong analytical and process optimization skills. Prior roles include clinical data analyst at the Children’s Hospital of Philadelphia, project coordinator at DSG, Inc., and iSTAR research scholar at the Indian Institute of Technology, Madras, with research published in significant academic proceedings. Arun holds both a Master of Science and a Bachelor of Science in Biomedical Engineering from Drexel University.